Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | P124L |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | PIK3CA P124L does not lie within any known functional domains of the Pik3ca protein (UniProt.org). P124L results in activation of Pik3ca signaling as indicated by increased Akt phosphorylation in cell culture (PMID: 22430209), and therefore, is predicted to lead to a gain of Pik3ca protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PIK3CA mutant PIK3CA act mut PIK3CA P124L |
Transcript | NM_006218.4 |
gDNA | chr3:g.179199708C>T |
cDNA | c.371C>T |
Protein | p.P124L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_006218 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
NM_006218.3 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
XM_006713658 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
XM_011512894.2 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
XM_011512894 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179199708C>T | c.371C>T | p.P124L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PIK3CA P124L | urinary bladder cancer | resistant | MK2206 | Preclinical - Cell culture | Actionable | In a preclinical study, a bladder cancer cell line harboring PIK3CA P124L was resistant to MK2206 in culture (PMID: 25349966). | 25349966 |